Latest updates
- In the press Exonate appoints Dr Rafiq Hasan as Non-Executive Director
- In the press Exonate Shortlisted for Biotech Company of the Year by The Cambridge Independent Science and Technology Awards.
- In the press Exploristics and Exonate announce successful collaboration to enhance clinical trial study design using cloud-based simulation
- In the press Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema
- Insights Biotech Showcase, San Francisco 2024
- In the press Exonate announces successful completion of Phase Ib/IIa trial in diabetic macular oedema